MacConaill, Laura E.
Brigham and Women's Hospital · Dana-Farber Cancer Institute · Dana-Farber Brigham Cancer Center
6 papers on CoChatORCID 0000-0002-0220-4715
Most cited papers
- Verified
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature
Cancer Genomics and DiagnosticsComputational Drug Discovery Methods
Cited by 7,950
- Verified
AACR Project GENIE: Powering Precision Medicine through an International Consortium
The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery
Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations
Cited by 1,964
- Verified
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics
Telomeres, Telomerase, and SenescenceDNA Repair Mechanisms
Cited by 629
- Verified
Institutional implementation of clinical tumor profiling on an unselected cancer population
Sholl, L. M., Do, K., Shivdasani, P., Cerami, E., Dubuc, A. M., Kuo, F. C., Garcia, E. P., Jia, Y., Davineni, P., Abo, R. P., et al. (2016) · JCI Insight
Cancer Genomics and DiagnosticsGenomics and Rare Diseases
Cited by 450
- Verified
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Harris, M. H., DuBois, S. G., Glade Bender, J. L., Kim, A., Crompton, B. D., Parker, E., Dumont, I. P., Hong, A. L., Guo, D., Church, A., et al. (2016) · JAMA Oncology
Cancer Genomics and DiagnosticsGenomics and Rare Diseases
Cited by 206
- Verified
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Nassar, A. H., Adib, E., Abou Alaiwi, S., El Zarif, T., Groha, S., Akl, E. W., Nuzzo, P. V., Mouhieddine, T. H., Perea-Chamblee, T., Taraszka, K., et al. (2022) · Cancer Cell
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 121
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free